Objectives: In 60 healthy humans, a blend of commonly used edible vegetable fats was compared with the same fat blend after random chemical interesteri®cation, for their effects in terms of nutritional safety on blood lipids, blood enzymes and hemostasis parameters. Design: Both fat blends were supplied double-blind at two energy levels (4 and 8% of energy) in margarine according to a parallel design. At either energy level, the two fat blends were consumed according to a cross-over design for two periods of three weeks, without an intermediate wash-out period. Results: The 30 parameters studied revealed no statistically signi®cant differences between the two fat blends, except for slightly ( $ 10%) lower D-dimers concentrations after consumption of the interesteri®ed fat blend. Conclusions: Increased levels of the ®brin-degradation products D-dimers are positively associated with risk for coronary heart disease. Thus, it was concluded that the inclusion of a chemically interesteri®ed vegetable fat blend in the diet of healthy people does not in¯uence fasting blood lipids, blood enzymes and/or hemostasis parameters in an adverse way, when compared with a non-interesteri®ed fat blend with the same fatty acid composition.
Introduction
Interesteri®cation of triglycerides has been used for many years to modify edible fats and oils. The process is functional for the food industries because it leads to different melting and crystallisation behaviour of the fat. Hardening of liquid oil through interesteri®cation with solid fat offers an alternative to the use of partial hydrogenation in margarine and spread manufacture. During interesteri®cation the arrangement of the fatty acids on the glycerol backbone of a triglyceride is changed, without producing or introducing trans fatty acids or positional isomers of fatty acids. The product of the most widely practised chemical catalysed interesteri®cation process is a triglyceride where the fatty acids are randomly distributed over the glycerol backbone.
Possible direct nutritional consequences of interesteri®-cation could be expected for the process of triglyceride absorption. This process starts with the splitting off of the fatty acids at the sn-1,3 positions of the triglyceride under the in¯uence of intestinal lipases (Small, 1991) . The remaining 2-monoglyceride is ef®ciently absorbed. The degree of absorption of the free fatty acids is dependent on their type (Matton et al, 1979) . Following absorption, in the enterocyte the 2-monoglyceride is resynthesised into a triglyceride, incorporated in chylomicrons, and secreted into lymph (Small, 1991) . The chylomicron triglycerides largely retain (approximately 75%) of the original fatty acid at the sn-2 position. However, the fatty acids at the sn-1,3 positions tend towards a random selection of active fatty acids in the intestinal mucosal cell.
Fatty acids attached to the sn-2 position of triglycerides in chylomicrons might be preferentially transported to the liver instead of to the extrahepatic tissues because lipoprotein lipase primarily hydrolyses the sn-1,3 positions of triglycerides. The hepatocyte is the major site of action of fatty acids on LDL-metabolism (Spady et al, 1993) . In line with the hypothesis by Dietschy's group that in the hepatocyte saturated fatty acids inhibit cholesterol esteri®cation and elevate the ratio of cholesterol over cholesteryl esters (Spady et al, 1993) , saturated fatty acids at the sn-2 position of dietary triglycerides might elevate LDL concentrations more than the same fatty acids at the sn-1,3 positions. In vegetable fats and oils (long chain) saturated fatty acids are largely located at the sn-1,3 positions. Thus, especially random interesteri®ca-tion of these fats could alter the in¯uence of the fat on lipid metabolism.
With respect to the effect of interesteri®cation of dietary fats on blood lipids, three recent studies indicated that large differences in dietary fatty acid con®guration has negligible effects on fasting or postprandial blood lipoprotein concentrations in humans (Zock et al, 1995; Nestel et al, 1995; Zampelas et al, 1994) . Two other reports of studies in humans concluded that random interesteri®cation of butter fat lowered the (postprandial) hypercholesterolemic effect of this fat (Christophe et al, 1978; Mutanen et al, 1996) . No other human trials have been reported, designed to directly compare commonly used dietary fat blends after chemical interesteri®cation, in terms of nutritional safety, with similar non-interesteri®ed fat blends on blood lipids, clinical chemical, and/or hemostasis parameters. The present study investigated the effect of chemical interesteri®cation of a blend of vegetable oils on fasting blood lipids, blood enzymes, and hemostatis parameters in healthy human subjects.
Methods
We had this strictly controlled dietary study conducted, according to Good Clinical Practice, in a double-blind fashion, at the TNO Nutrition and Food Research Institute, Zeist, the Netherlands. The study protocol was approved by the TNO Medical Ethical Committee.
Subjects
Subjects were recruited from the pool of volunteers of the TNO Nutrition and Food Research Institute and by advertisements in local newspapers. No TNO-employees were included. Respondents received a verbal brie®ng and a copy of written information. They ®lled in two copies of the informed consent form, one of which they retained, and a questionnaire on personal data, life style, disease history and dietary habits. Each of the respondents was medically examined after an overnight fast for urine and blood collection. After examination, instructions were given by a dietician on a three-day diary to be ®lled in. Routine blood chemistry and hematology and urinalysis was performed. None of the volunteers included in the study did suffer from anemia, glucosuria, or proteinuria, and they were apparently healthy, did not use vitamin or any other nutritional supplements, and were not on a diet for medical reasons. Some characteristics of the subjects on entry in the study are given in Table 1 . Post study screening (physical examination, and routine blood chemistry, hematology and urinalysis) was performed within a week after the last blood sampling of the dietary phase.
Experimental design
A fat blend was composed of 36% (w/w) coconut fat, 33% palm oil, 22% dry-fractionated palm oil-stearin fraction, and 9% low-trans partially hydrogenated rapeseed oil. Part of this fat blend was used as such. The remainder was chemically interesteri®ed using sodium-methylate (0.05%) as a catalyst, according to standard food industries protocols. The non-interesteri®ed and the interesteri®ed fat blends were re®ned, and each of the two so called hardstocks was mixed with soybean oil in a ratio of 58:42. Preparation of two margarines containing 80% of the mixed fats was performed at Unilever Research Laboratory Vlaardingen, according to Good Manufacturing Practice. Characterization and determination of the homogeneity and stability of the margarines was performed according to Good Laboratory Practice. The fatty acid pro®le and the positional distribution of the triglycerides in the margarines are given in Table 2 . Essentially, interesteri®cation resulted in relatively more myristic (C14:0), palmitic (C16:0), and stearic (C10:0) acids of the sn-z position, at the expense of lauric (C12:0) and oleic (C18:1) acids. During interesteri®cation, esteri®cation of tocopherols and tocotrienols appeared to be negligible (data not shown).
Either fat blend was supplied at two levels of energy, 4 en% and 8 en%, according to a parallel design to 32 subjects. The 4 en% fat blend level corresponded with a margarine intake of 20±40 g per day, namely 7 en%, in this group of volunteers. This range would comprise the average daily margarine intake of most Western countries. The higher level of fat blend (8 en% 14 en% of margarine) was included in the study to enable drawing conclusions on the effect of interesteri®cation of fats at substantially higher than average margarine intake levels. Typically, at the 4 en% fat blend level, interesteri®cation resulted in an increased dietary intake of palmitic acid at the sn-2 position of about 0.25 en% and a decreased intake of oleic acid at that position of about 0.15 en%. In either energy level group, the two fat blends were supplied to all subjects according to a cross-over design, with each fat blend being included in the diet for a period of three weeks. Each experimental group included equal numbers of males and females. The selected males and females were clustered in groups of four subjects of the same sex, based on their age, BMI and serum total cholesterol concentration. Individuals from each cluster were randomly allocated to one of the four experimental conditions at entrance. All subjects participated simultaneously from March 22 to May 4, 1995. During the study, subjects maintained their daily routines. The objective of the study was to investigate the effect of interesteri®cation of a blend of vegetable oils on blood lipids, blood enzymes, and hemostasis parameters. The statistical power of the trial as executed, for the parameters measured, is given in Table 3 . Characteristics are given for those subjects that completed the study, and were included in the statistical analyses. a Average value in three samples taken at the beginning, middle, and end of either margarine production. b c cis-isomers; t trans-isomers: these values were determined in the fat blends prior to margarine production.
Individual energy intake was calculated using a threeday (two working and one weekend day) dietary record method (Cameron & van Staveren, 1988 ) and the NEVO Food Composition Table ( 1993) . A 10% surplus was added to the calculated energy level to correct for underreporting.
The margarines containing the fat blends were provided to the volunteers as an ingredient in cake and as margarine for spreading on bread. Whole diets were provided at ten different levels of energy to meet the habitual energy intake of all subjects. The energy content of the daily diets was between 2000 and 4250 kcal (8.4 and 17.8 MJ), with incremental steps of 250 kcal (1 MJ). The diets were composed to be nutritionally adequate and to meet the dietary guidelines of the Netherlands Food and Nutrition Board. All food was provided and the volunteers were instructed not to consume any other food than that supplied. Compliance with the diets was improved by recording of uncomsumed products, asking for additional food consumption, and rating of the feeling of hunger on adverse events forms. Dinner was provided daily at the metabolic unit of the TNO Institute between 5 and 7 pm. After dinner, the foods for snacking, breakfast and lunch until dinner on the next day were provided. Dietary adjustments were made when a weight gain or loss had occurred on two consecutive weighing days that was greater than 1.5 kg. Diets were also adjusted when minor weight changes were accompanied by complaints about the amount of food.
Measurements
The volunteers daily ®lled in a questionnaire on adverse events and on compliance with the foodstuffs. Body weights were determined twice a week. At the end of each three-week dietary period, blood samples were collected from each subject on two separate days with a twoday interval. Blood was sampled from the cubital vein after an overnight fast. Blood was mixed with clot activator for determination of serum chemistry: Alkaline phosphatase, AP; alanine transaminase, ALT; aspartate transaminase, AST; g-glutamate transaminase, g-GT; lactate dehydrogenase, LDH, a-hydroxybutyrate dehydrogenase, a-HBDH; total bilirubin; total protein; albumin; C-reactive protein, CRP, creatinine; urea; glucose; triglycerides; total cholesterol; HDL-cholesterol, after precipitation with polyethylene glycol according to Siedel et al (1983) ; and free fatty acids (FFA) were determined using test combinations purchased from Boehringer, Mannheim, Germany. Serum LDL-cholesterol concentration was calculated using the formula by Friedewald et al (1972) . Serum lipoprotein [a] (Lp[a]) concentration was analyzed using the test combination from DAKO products, Glostrup, Denmark. Whole serum fatty acids was analyzed using a standard method (AOCS Ce 1-62). Stabylite blood was used for determination of tissue-plasminogen activator (tPA) activity (Meijer et al, 1992) . Buffered and non-buffered citrate blood was used for determination of plasma ®brinogen, using the reagent from DiaMed (DiaMed AG, Cressier sur Monat, Switzerland) on a Biomatic 2000 analyzer (Sarstedt BV, Einhoven, Netherlands), and the activated form of coagulation factor VII (Factor VIIa) (Morrissey et al, 1993) , respectively.
Citrate-Theophylline-Adenosine-Dipyridamole (CTAD) blood was used for analysis of tPA-antigen (Ranby et al, 1986) , plasminogen activator-inhibitor-1 (PAI-1)-antigen (Meijer et al, 1994) , D-dimers (using the Enzygnost 1 micro method from Behringwerke, Marburg, Germany), and von Willebrand Factor (vWF) (Silveira et al, 1986) . EDTA-blood was used for the determination of LDL oxidation parameters (Princen et al, 1992) , only in the samples taken on the ®rst day of each of two-days sampling period.
Characterization (mean value) and homogeneity (CV; coef®cient of variance) of the margarines was determined by measuring water (AOCSce 920.116) and fat content, by Table 3 The statistical power of the study as executed (n 60) for the detection of an overall signi®cant difference between fat blends at the probability level of P 0.05, expressed as percent of the grand mean
Grand mean Difference (%) extraction with dichloromethane after lyophilization, overall fatty acid pro®le (AOCS Ce 1-62), and fatty acid pro®le at the sn-2 position (Off J Eur Commun, 1991; IUPAC, 1987) in three samples taken at the beginning, middle and end of the manufacture. Stability of the margarines was determined by performing the same analyses and by determination of the peroxide value (AOCS Cd 8b-90) in margarine samples that were returned by the TNO Institute at the end of the dietary phase. Samples of total diets were analyzed for crude protein (ISO 5983-1979) , total fat (Pardun, 1969) , fatty acids (AOCS Ce 1-62), total carbohydrates (Van de Kramer, 1941), mono-and disaccharides (Richter & Woelk, 1977) , cholesterol and plant sterols (NEN 6328, 6364, 6365; Netherlands Normalisation Institute, Delft, Netherlands), dietary ®bre (total and soluble) (Prosky et al, 1988) , vitamin E (Speek et al, 1985) , total carotenoids and b-carotene (Speek et al, 1986) , and vitamin C (Speek et al, 1984) .
Statistical analysis
Data are expressed as the mean AE standard deviation. Data which were not distributed normally were ln transformed before further statistical analysis. Differences between means were evaluated by a two-sided ANOVA, using the following factors: type of fat blend, energy level, gender, and repeated measure. All possible interactions were also evaluated. The null hypothesis was rejected at the 0.05 level of probability. The statistical analyses were performed using Genstad TM 5 Release 3 (The Numerical Algorithms Group, Limited, Oxford, UK).
Results
The overall fatty acid pro®le, and that at the sn-2 position, of each of the two margarines were homogeneous (CV`5%). Also the fat and water levels in the two margarines were homogeneous (CV`3%). During the human trial, no complaints with regard to margarine taste were recorded.
The whole diets were analyzed as described and the results are given in Table 4 . Apart from ( $ 16%) lower cholesterol concentrations in both diets containing 8 en% of the fat blends, the four types of diet were very similar in their macro and micro nutrient compositions. The effect of this difference in dietary cholesterol level ( $ 4 mg/MJ) would have caused an insigni®cant change of 0.03 mM in serum total cholesterol concentration (Hegsted et al, 1993) .
During the dietary phase of the study, two female subjects discontinued for unknown reasons. To maintain a balanced design, two other subjects were excluded from the statistical analysis. Consequently, a total of 60 subjects was included for the calculations on all data and statistical analysis, as shown in Table 1 .
Body weights dropped slightly but statistically signi®-cantly in the ®rst and second three-week dietary period of the study (0.18 kg/week and 0.16 kg/week, respectively). However, body weight loss never exceeded the pre-set value of 1.5 kg. There were no differences in body weight between the types and levels of energy of the fat blends, suggesting that changes in body weight would not have interfered with the outcomes of this study.
No differences in the whole serum fatty acid distribution were observed between the two fat blends (Table 5) .
Analysis of blood clinical chemical characteristics revealed no signi®cant differences between the two fat blends (Table 6 ). Activity of g-GT was higher after the 8 en% diets when compared with the 4 en% diets. Activities of AP, ALT, and AST as well as concentrations of bilirubin, creatinine, and urea were signi®cantly lower in women than in men.
Neither the type of fat blend, nor the energy level at which the fat blends were consumed resulted in signi®cant changes in blood lipid values (Table 7) . Total and HDLcholesterol concentrations and vitamin E levels were signi®cantly higher in females. Free fatty acids were lower in men than in women in the 4 en% groups, whereas the opposite was seen in the 8 en% group.
No signi®cant differences in hemostasis parameters were observed between fat blends or energy levels in the diet, except for D-dimers concentration (Table 8) . Following logarithmic transformation, D-dimers levels were signi®cantly lower after consumption of the interesteri®ed fat blend. In addition, males had lower D-dimers levels than females. 
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The following fatty acids were not detectable: C18:1 c6; C18:1 t11; C18:2 t9,12; C20:0; C20:1; C22:0; C22:1. b c cis-isomer; t trans-isomer. 
Discussion
In this study the effect of random interesteri®cation of a blend of commonly used edible vegetable fats, consumed at realistic intake levels, on various parameters, including risk factors for Coronary Heart Disease (CHD), was evaluated.
In this double-blind placebo-controlled trial with healthy volunteers, the interesteri®ed fat was compared with the same fat blend, but not interesteri®ed, at two levels of energy intake. The main purpose of the current study was to evaluate the nutritional safety of interesteri®ed fats at realistic intake levels. At the higher intake level of energy, both fat blends increased serum g-GT activity. The physiological implication of this isolated ®nding is not clear. Interesteri®cation of the fat blend did not lead to statistically signi®cant effects on any of the measured parameters, except for ( $ 10%) lower D-dimers concentrations. Increased levels of D-dimers have been positively associated with risk for CHD in patients with peripheral artery disease (Fowkes et al, 1993) . Concentrations in the upper two quintiles increased the relative risk for fatal and non-fatal coronary events in these patients. Also in apparently healthy men, with baseline D-dimers concentrations exceeding the 95th percentile of the control distribution, the risk for coronary events was two times higher than that for individuals with lower levels (Ridker et al, 1994) . The observed effect of Ddimers concentration in our study was relatively small, and changes in the D-dimers concentration were not accompanied by other changes in the coagulation or ®brinolytic factors measured. Thus, the observed decrease of D-dimers level after consumption of the margarine containing the interesteri®ed fat blend was not considered to be meaningful.
Rat studies (De Fouw et al, 1994; Brink et al, 1995) indicating that palmitic and stearic acids are less well absorbed ( $ 10% reduction) when occupying the sn-1,3 positions of triglycerides relative to the sn-2 position. This effect was enhanced, namely the absorption from the sn-1,3 positions was further decreased (up to $ 15% reduction), at high calcium intakes. Palmitic acid must be considered as hypercholesterolemic (Spady et al, 1993; Temme et al, 1996) . However, no sigi®cant effects of the positional distribution of palmitic acid on plasma lipids was observed in rats (De Fouw et al, 1994; Renaud et al, 1995) . In contrast, piglets fed structured triglyceride containing palmitic acid predominantly at the sn-2 position showed higher plasma total and HDL-cholesterol concentrations than those fed palm oil with palmitic acid predominantly at the sn-1,3 positions (Innis et al, 1993) .
Several human studies have been performed using chemically interesteri®ed fats to obtain speci®c fatty acid compositions. Although not designed to investigate the effect of interesteri®cation of fats, these studies indicate that such fats affect blood lipids as would be expected from their gross fatty acid composition, for example Bonanome & Grundy, 1988; Tholstrup et al, 1994 . A few human studies have been published, that directly compared very high levels of dietary triglycerides speci®cally differing in their positional distribution of palmitic versus oleic acid. Zock et al (1995) showed that an extreme contrast of 10 en% in these types of fatty acid at the sn-2 position had negligible effects on fasting blood lipoprotein levels in humans consuming the experimental fats at high concentrations. In addition, Zampelas et al (1994) using similar fats, concluded that the positional distribution of these fatty acids is not an important determinant of postprandial lipemia. Another study by Nestel et al (1995) demonstrated that random interesteri®cation, leading to considerable enrichment of the sn-2 position by palmitic acid and a corresponding loss from this position of oleic and linoleic acids, did not affect fasting plasma lipoprotein levels.
Two examples of structured triglycerides, Caprenin TM (a randomized triglyceride primarily comprising caprylic, capric and behenic acids) and Salatrim TM (triglycerides composed of mixtures of long-chain saturated fatty acids, predominantly stearic acid, and the short chain fatty acids acetic, propionic, and/or butyric acids), have been claimed to be low-caloric as based on animal and human studies Finley et al, 1994a) . Caprenin TM has been reported to be hypercholesterolemic in men (Wardlaw et al, 1995) , whereas very limited data suggest that Salatrim TM does not in¯uence blood cholesterol levels (Finley et al, 1994b) .
The human studies performed so far, using very high concentrations of the hypercholesterolemic palmitic acid in experimental fat blends, did not support the hypothesis that dietary triglycerides enriched with saturated fatty acids at the sn-2 position elevate blood lipoprotein concentrations more than triglycerides containing these fatty acids at the sn-1,3 positions. We studied the effects of interesteri®ca-tion of a blend of commonly used vegetable oils at much lower and more realistic levels of human intake, in relatively young normocholesterolemic adults. Thus, as had been anticipated, the resulting moderate enrichment of the sn-2 position by longer-chain saturated fatty acids did not affect blood lipid levels. Thus the data available so far favour the conclusion that interesteri®cation of dietary triglycerides as such does not adversely in¯uence blood lipid concentrations. In addition to measuring no effects on blood lipids, our study also showed no adverse effect of interesteri®cation on various clinical chemical and hemostasis parameters. To the best of our knowledge, our study is the ®rst to report on the effect of random interesteri®ca-tion of dietary fats on such parameters.
Conclusions
We conclude that interesteri®cation of a blend of commonly used vegetable oils did not affect fasting blood lipids, clinical chemical and hemostasis parameters, including risk factors for CHD in healthy humans, differently from a fat blend with the same fatty acid composition. This observation is of importance in terms of nutritional safety, because interesteri®cation of edible fats offers an alternative to the use of trans fatty acids for food industries.
